Consistently, in hepatocellular carcinoma (HCC) cells, hnRNPA2B1 is degraded by miR503HG specifical interaction, which promotes the metabolism of p52 and p65 mRNA, inhibits the NF-κB signaling pathway, and thereby suppresses HCC metastasis (37). This evidence concerns the gene HNRNPA2B1 and hepatocellular carcinoma.